scispace - formally typeset
J

James E. Udelson

Researcher at Tufts Medical Center

Publications -  407
Citations -  43252

James E. Udelson is an academic researcher from Tufts Medical Center. The author has contributed to research in topics: Heart failure & Coronary artery disease. The author has an hindex of 93, co-authored 387 publications receiving 38834 citations. Previous affiliations of James E. Udelson include University of Minnesota & American College of Cardiology.

Papers
More filters
Journal ArticleDOI

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

TL;DR: Intracoronary administration of rFGF-2 appears safe and is well tolerated over a 100-fold dose range (0.33 to 0.36 microk/kg) and preliminary evidence of efficacy is tempered by the open-label uncontrolled design of the study.
Journal ArticleDOI

Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction.

TL;DR: In patients with LV systolic dysfunction, warfarin use is associated with improved survival and reduced morbidity, primarily due to a reduction in cardiac events and does not appear to be limited to any particular subgroup.

Cardiovascular Function and Treatment in β-Thalassemia Major A Consensus Statement From the American Heart Association Endorsed by the Thalassaemia International Federation, European Society of Cardiology Working Group on Cardiovascular Magnetic Resonance, and Society for Cardiovascular Magnetic Resonance

TL;DR: An expert consensus is reported on the diagnosis and treatment of cardiac dysfunction in β-thalassemia major (TM), which does not cover other hemoglobinopathies, including thalassemia intermedia and sickle cell anemia, in which a different spectrum of cardiovascular complications is typical.